Allogene Therapeutics is a clinical-stage biotechnology company that is at the forefront of developing allogeneic chimeric antigen receptor T cell (AlloCAR T™) products. Their mission is to revolutionize cell therapy and advance immunologic treatments. With a focus on external supply and a team of dedicated professionals, Allogene Therapeutics is committed to making significant contributions to the field of biotechnology.

Allogene Therapeutics, Inc. Associate Director, External Supply. October 2018 - Present. United States Air Force, ...

Allogene Therapeutics. @AllogeneTx. We are a clinical-stage biotechnology company pioneering the development of allogeneic CAR T(“AlloCAR T™”) products for ...

Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell ...

Allogene Therapeutics

Find contacts at this company